NCT07161518View on ClinicalTrials.gov

Characterizing Transcranial Focused Ultrasound Neuromodulation During Sedation

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2027

Conditions
Healthy Participants
Interventions
DEVICE

Low-intensity transcranial ultrasound

Active (focused) ultrasound

DEVICE

Low-intensity transcranial ultrasound

Sham (unfocused) ultrasound

DRUG

Propofol

Intravenous propofol administration

Trial Locations (1)

94305

Stanford University, Palo Alto

All Listed Sponsors
lead

Stanford University

OTHER